Logo image of BC.MI

BRUNELLO CUCINELLI SPA (BC.MI) Stock Fundamental Analysis

BIT:BC - Euronext Milan - IT0004764699 - Common Stock - Currency: EUR

106.4  -2.05 (-1.89%)

Fundamental Rating

4

Taking everything into account, BC scores 4 out of 10 in our fundamental rating. BC was compared to 41 industry peers in the Textiles, Apparel & Luxury Goods industry. While BC belongs to the best of the industry regarding profitability, there are concerns on its financial health. BC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

BC had positive earnings in the past year.
In the past year BC had a positive cash flow from operations.
BC had positive earnings in 4 of the past 5 years.
Each year in the past 5 years BC had a positive operating cash flow.
BC.MI Yearly Net Income VS EBIT VS OCF VS FCFBC.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

BC has a Return On Assets of 6.85%. This is in the better half of the industry: BC outperforms 70.73% of its industry peers.
The Return On Equity of BC (24.39%) is better than 82.93% of its industry peers.
The Return On Invested Capital of BC (11.52%) is better than 68.29% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BC is in line with the industry average of 10.00%.
The last Return On Invested Capital (11.52%) for BC is above the 3 year average (11.50%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.85%
ROE 24.39%
ROIC 11.52%
ROA(3y)7.08%
ROA(5y)4.55%
ROE(3y)23.8%
ROE(5y)15.09%
ROIC(3y)11.5%
ROIC(5y)N/A
BC.MI Yearly ROA, ROE, ROICBC.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

Looking at the Profit Margin, with a value of 9.34%, BC is in the better half of the industry, outperforming 68.29% of the companies in the same industry.
In the last couple of years the Profit Margin of BC has grown nicely.
With a decent Operating Margin value of 16.57%, BC is doing good in the industry, outperforming 70.73% of the companies in the same industry.
In the last couple of years the Operating Margin of BC has grown nicely.
The Gross Margin of BC (92.23%) is better than 100.00% of its industry peers.
BC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.57%
PM (TTM) 9.34%
GM 92.23%
OM growth 3Y15.25%
OM growth 5Y3.85%
PM growth 3Y7.67%
PM growth 5Y1.56%
GM growth 3Y2.95%
GM growth 5Y0.83%
BC.MI Yearly Profit, Operating, Gross MarginsBC.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BC is still creating some value.
BC has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, BC has about the same amount of shares outstanding.
The debt/assets ratio for BC is higher compared to a year ago.
BC.MI Yearly Shares OutstandingBC.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BC.MI Yearly Total Debt VS Total AssetsBC.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 5.13 indicates that BC is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.13, BC belongs to the top of the industry, outperforming 85.37% of the companies in the same industry.
BC has a debt to FCF ratio of 10.76. This is a negative value and a sign of low solvency as BC would need 10.76 years to pay back of all of its debts.
The Debt to FCF ratio of BC (10.76) is worse than 73.17% of its industry peers.
BC has a Debt/Equity ratio of 1.62. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.62, BC is doing worse than 90.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.62
Debt/FCF 10.76
Altman-Z 5.13
ROIC/WACC1.42
WACC8.12%
BC.MI Yearly LT Debt VS Equity VS FCFBC.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

BC has a Current Ratio of 1.40. This is a normal value and indicates that BC is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.40, BC is not doing good in the industry: 63.41% of the companies in the same industry are doing better.
A Quick Ratio of 0.65 indicates that BC may have some problems paying its short term obligations.
The Quick ratio of BC (0.65) is worse than 78.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.65
BC.MI Yearly Current Assets VS Current LiabilitesBC.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

1

3. Growth

3.1 Past

BC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
BC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.36%.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)16.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.48%

3.2 Future

Based on estimates for the next years, BC will show a very negative growth in Earnings Per Share. The EPS will decrease by -22.98% on average per year.
The Revenue is expected to grow by 5.73% on average over the next years.
EPS Next Y1.97%
EPS Next 2Y17.03%
EPS Next 3Y12.21%
EPS Next 5Y-22.98%
Revenue Next Year14.11%
Revenue Next 2Y10.67%
Revenue Next 3Y10.48%
Revenue Next 5Y5.73%

3.3 Evolution

BC.MI Yearly Revenue VS EstimatesBC.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
BC.MI Yearly EPS VS EstimatesBC.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 200.75, BC can be considered very expensive at the moment.
75.61% of the companies in the same industry are cheaper than BC, based on the Price/Earnings ratio.
BC's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.29.
With a Price/Forward Earnings ratio of 146.03, BC can be considered very expensive at the moment.
63.41% of the companies in the same industry are cheaper than BC, based on the Price/Forward Earnings ratio.
BC is valuated expensively when we compare the Price/Forward Earnings ratio to 22.17, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 200.75
Fwd PE 146.03
BC.MI Price Earnings VS Forward Price EarningsBC.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

78.05% of the companies in the same industry are cheaper than BC, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BC indicates a rather expensive valuation: BC more expensive than 82.93% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 80.79
EV/EBITDA 22.18
BC.MI Per share dataBC.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of BC may justify a higher PE ratio.
A more expensive valuation may be justified as BC's earnings are expected to grow with 12.21% in the coming years.
PEG (NY)101.71
PEG (5Y)N/A
EPS Next 2Y17.03%
EPS Next 3Y12.21%

More info and screens

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.88%, BC is not a good candidate for dividend investing.
BC's Dividend Yield is slightly below the industry average, which is at 3.39.
Compared to an average S&P500 Dividend Yield of 2.38, BC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.88%

5.2 History

The dividend of BC is nicely growing with an annual growth rate of 26.43%!
Dividend Growth(5Y)26.43%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

55.33% of the earnings are spent on dividend by BC. This is a bit on the high side, but may be sustainable.
The Dividend Rate of BC has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP55.33%
EPS Next 2Y17.03%
EPS Next 3Y12.21%
BC.MI Yearly Income VS Free CF VS DividendBC.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M
BC.MI Dividend Payout.BC.MI Dividend Payout, showing the Payout Ratio.BC.MI Dividend Payout.PayoutRetained Earnings

More info and screens

BRUNELLO CUCINELLI SPA

BIT:BC (6/2/2025, 7:00:00 PM)

106.4

-2.05 (-1.89%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)04-16 2025-04-16
Earnings (Next)07-10 2025-07-10
Inst Owners34.26%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.24B
Analysts76.52
Price Target117.2 (10.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.88%
Yearly Dividend0.97
Dividend Growth(5Y)26.43%
DP55.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2%
Min Revenue beat(2)-3.83%
Max Revenue beat(2)-0.16%
Revenue beat(4)0
Avg Revenue beat(4)-2.18%
Min Revenue beat(4)-3.83%
Max Revenue beat(4)-0.16%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.86%
PT rev (3m)-1.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.53%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.41%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-3.41%
Revenue NY rev (1m)-0.28%
Revenue NY rev (3m)-0.96%
Valuation
Industry RankSector Rank
PE 200.75
Fwd PE 146.03
P/S 5.66
P/FCF 80.79
P/OCF 38.3
P/B 14.77
P/tB 15.28
EV/EBITDA 22.18
EPS(TTM)0.53
EY0.5%
EPS(NY)0.73
Fwd EY0.68%
FCF(TTM)1.32
FCFY1.24%
OCF(TTM)2.78
OCFY2.61%
SpS18.8
BVpS7.2
TBVpS6.96
PEG (NY)101.71
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.85%
ROE 24.39%
ROCE 16.89%
ROIC 11.52%
ROICexc 13.39%
ROICexgc 13.58%
OM 16.57%
PM (TTM) 9.34%
GM 92.23%
FCFM 7%
ROA(3y)7.08%
ROA(5y)4.55%
ROE(3y)23.8%
ROE(5y)15.09%
ROIC(3y)11.5%
ROIC(5y)N/A
ROICexc(3y)13.12%
ROICexc(5y)N/A
ROICexgc(3y)13.32%
ROICexgc(5y)N/A
ROCE(3y)16.97%
ROCE(5y)N/A
ROICexcg growth 3Y23.78%
ROICexcg growth 5Y9.26%
ROICexc growth 3Y24.24%
ROICexc growth 5Y9.52%
OM growth 3Y15.25%
OM growth 5Y3.85%
PM growth 3Y7.67%
PM growth 5Y1.56%
GM growth 3Y2.95%
GM growth 5Y0.83%
F-Score6
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 1.62
Debt/FCF 10.76
Debt/EBITDA 2.17
Cap/Depr 64.95%
Cap/Sales 7.77%
Interest Coverage 7.42
Cash Conversion 51.78%
Profit Quality 74.95%
Current Ratio 1.4
Quick Ratio 0.65
Altman-Z 5.13
F-Score6
WACC8.12%
ROIC/WACC1.42
Cap/Depr(3y)55.1%
Cap/Depr(5y)51.31%
Cap/Sales(3y)7.01%
Cap/Sales(5y)7.44%
Profit Quality(3y)127.84%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y1.97%
EPS Next 2Y17.03%
EPS Next 3Y12.21%
EPS Next 5Y-22.98%
Revenue 1Y (TTM)16.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.48%
Revenue Next Year14.11%
Revenue Next 2Y10.67%
Revenue Next 3Y10.48%
Revenue Next 5Y5.73%
EBIT growth 1Y12.97%
EBIT growth 3Y40.07%
EBIT growth 5Y20.51%
EBIT Next Year88.34%
EBIT Next 3Y32.03%
EBIT Next 5Y23.81%
FCF growth 1Y-33.92%
FCF growth 3Y-16.66%
FCF growth 5Y6.61%
OCF growth 1Y-9.62%
OCF growth 3Y-3.18%
OCF growth 5Y10.42%